Ian Michael Estepan Sarepta Therapeutics, Inc. (SRPT) insider trading activity

Ian Michael Estepan is Chief Operating Officer of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 193,300 shares of SRPT, which is worth approximately $3.64 Million. The most recent transaction as insider was on Mar 07, 2022, when has been sold 398 shares (Common Stock) at a price of $79.36 per share, resulting in proceeds of $31,585. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K

6.39% 3M change

473.66% 12M change

Total Value Held $3.64 Million

Ian Michael Estepan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2022	SELL Payment of exercise price or tax liability	$31,585 $79.36 p/Share	398 Reduced 1.59%	24,671 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	-	8,000 Added 19.67%	32,671 Common Stock
Mar 04 2022	SELL Payment of exercise price or tax liability	$103,594 $79.2 p/Share	1,308 Reduced 4.96%	25,069 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$28,219 $75.05 p/Share	376 Reduced 1.41%	26,377 Common Stock
Sep 08 2021	SELL Payment of exercise price or tax liability	$127,065 $78.29 p/Share	1,623 Reduced 5.72%	26,753 Common Stock
Mar 03 2021	BUY Grant, award, or other acquisition	-	15,000 Added 34.06%	29,042 Common Stock

IME

Ian Michael Estepan

Chief Operating Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Value

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sarepta Therapeutics, Inc.

Track Activities on SRPT

Account